Saturday, November 23, 2024
HomeTagsPontifax

Pontifax

Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC

Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics